Dermatomyositis and lupus are autoimmune conditions that may share symptoms like skin rashes, muscle weakness, and chronic inflammation. Dermatomyositis may involve lung complications and skin ...

Systemic lupus erythematosus commonly presents as a rash. The rashes are caused by inflammation from the immune system fighting the body. Systemic lupus erythematosus, more commonly known as lupus ...

Lupus is a chronic (long-term) autoimmune disease that affects your entire body, leading to symptoms such as fatigue, arthritis, fever, and skin rashes. It may also cause less common symptoms such ...

Systemic lupus erythematosus, more commonly known as lupus, has a variety of symptoms and room for improvement when it comes to treatment. Cutaneous lupus erythematosus is a common manifestation ...

‘Could a prescription cream help with #lupus #rashes? Early research on #Mupirocin shows promise in reducing #inflammation, but more studies are needed. #skincare #research’ The study randomly ...

You might occasionally notice a new mark on your body, whether it's on your arm, thigh, or leg. While these marks are ... Additionally, clevelandclinic notes that a similar rash is commonly seen in ...

You might occasionally notice a new mark on your body, whether it's on your arm, thigh, or leg. While these ... that a similar rash is commonly seen in individuals with lupus.

Systemic lupus erythematosus, more commonly known as lupus, has a variety of symptoms and room for improvement when it comes to treatment. Cutaneous lupus erythematosus is a common manifestation ...

This episode of The Expert Series explores the complex relationship between lupus and fibromyalgia, focusing on definitions, symptoms, overlapping conditions, treatment approaches, mental health ...

Lupus panniculitis is a rare type of lupus. It causes painful lumps under the skin that may lead to scarring. Treatments can help reduce the risk of complications. Lupus is a chronic autoimmune ...

Obinutuzumab, a humanized type II anti-CD20 monoclonal antibody, provided significantly better renal responses than placebo in a phase 2 trial involving patients with lupus nephritis receiving ...